Company

Verisk Says Co To Proceed With AccuLynx Transaction Following Delaware Supreme Court Ruling; Says Transaction Remains Subject To The Satisfaction Of Customary Closing Conditions And FTC Review, No Guarantee That The Transaction Will Be Completed

Oct 23, 2026 · 12:02 PM ET· updated 55m ago

Verisk (NASDAQ:VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today issued the following statement in response to the Delaware Supreme Court order regarding the

Why It Matters

Verisk got the legal okay to buy AccuLynx, a company it wants. But the deal still needs final approvals and government review first.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

VRSK198.38

-4.95 (-2.43%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.